The Readout Meghana Keshavan STAT Plus: The surprising outperformance of a new drug against existing competitors, and other biotech updates
The Readout Elaine Chen STAT Plus: Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week
The Readout Elaine Chen STAT Plus: Wegovy linked to lower risk of alcohol use disorder in real-world study
The Readout Meghana Keshavan STAT Plus: More tumult at BIO amid the company’s fourth CEO in four years
The Readout Elaine Chen STAT Plus: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
